Published in Biochem Biophys Res Commun on September 17, 1984
1,2-Diacylglycerol and phorbol ester inhibit agonist-induced formation of inositol phosphates in human platelets: possible implications for negative feedback regulation of inositol phospholipid hydrolysis. Proc Natl Acad Sci U S A (1985) 1.73
Pharmacology of signaling induced by dopamine D(1)-like receptor activation. Pharmacol Ther (2010) 1.02
Catalytic properties of a purified phosphatidylinositol-4-phosphate kinase from rat brain. Biochem J (1986) 0.97
Modulation of inositol phospholipid metabolism by polyamines. Biochem J (1988) 0.87
An inhibitory role for the protein kinase C pathway in ovarian steroidogenesis. Studies with cultured swine granulosa cells. Biochem J (1986) 0.84
Differential effects of chlorpromazine on secretion, protein phosphorylation and phosphoinositide metabolism in stimulated platelets. Biochem J (1986) 0.81
Desensitization and resensitization of human platelets to 5-hydroxytryptamine at the level of signal transduction. Biochem J (1995) 0.79
The effects of phorbol ester, diacylglycerol, phospholipase C and Ca2+ ionophore on protein phosphorylation in human and sheep erythrocytes. Biochem J (1985) 0.78
R 59 022, a diacylglycerol kinase inhibitor. Its effect on diacylglycerol and thrombin-induced C kinase activation in the intact platelet. J Biol Chem (1985) 1.86
Single-run high-performance liquid chromatography of nucleotides, nucleosides, and major purine bases and its application to different tissue extracts. Anal Biochem (1985) 1.68
Alkaline phosphatase. I. Kinetics and inhibition by levamisole of purified isoenzymes from humans. Clin Chem (1976) 1.43
Kinetics and inhibition of alkaline phosphatases from canine tissues. Biochim Biophys Acta (1972) 1.41
Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther (1988) 1.29
Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. Am J Physiol (1987) 1.28
12-O-Tetradecanoylphorbol 13-acetate stimulates inositol lipid phosphorylation in intact human platelets. FEBS Lett (1984) 1.24
Cytochemical and biochemical studies of yeasts after in vitro exposure to miconazole. Antimicrob Agents Chemother (1977) 1.23
Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites. J Biol Chem (1985) 1.08
L-p-Bromotetramisole, a new reagent for use in measuring placental or intestinal isoenzymes of alkaline phosphatase in human serum. Clin Chem (1977) 1.00
The role of endogenously formed diacylglycerol in the propagation and termination of platelet activation. A biochemical and functional analysis using the novel diacylglycerol kinase inhibitor, R 59 949. J Biol Chem (1989) 0.95
Uptake and deamination of adenosine by blood. Species differences, effect of pH, ions, temperature and metabolic inhibitors. Biochim Biophys Acta (1969) 0.92
Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection. J Clin Invest (1995) 0.92
R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro. Thromb Haemost (1989) 0.91
Formation and release of nucleosides in the ischemic myocardium. Is the guinea-pig the exception? Basic Res Cardiol (1986) 0.90
Cardioprotective effects of mioflazine during 1 h normothermic global ischaemia in the canine heart. Cardiovasc Res (1984) 0.89
Serotonin-S2 receptor binding sites and functional correlates. Neuropharmacology (1984) 0.88
Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine. Hypertension (1996) 0.88
Mitochondrial function in myocardial stunning. J Mol Cell Cardiol (1991) 0.87
Stimulation by serotonin of 40 kDa and 20 kDa protein phosphorylation in human platelets. FEBS Lett (1984) 0.85
Relation between coronary artery stenosis and myocardial purine metabolism, histology and regional function in humans. J Am Coll Cardiol (1987) 0.85
The antiarrhythmic effects of the nucleoside transporter inhibitor, R75231, in anaesthetized pigs. Br J Pharmacol (1993) 0.85
Protective effect of levamisole and its sulfhydryl metabolite OMPI against cell death induced by glutathione depletion. Int J Immunopharmacol (1979) 0.84
Changes in creatine phosphate, inorganic phosphate, and the purine pattern in dog hearts with time of coronary artery occlusion and effect thereon of mioflazine, a nucleoside transport inhibitor. Cardiovasc Res (1986) 0.84
Functional expression of the amplification reaction between serotonin and epinephrine on platelets. J Cardiovasc Pharmacol (1988) 0.84
The synergistic effect of 5-hydroxytryptamine and epinephrine on the human platelet is related to the activation of phospholipase C. Eur J Pharmacol (1993) 0.83
The effect of drugs on calmodulin and its interaction with phosphodiesterase. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 0.82
Optimization of a high-performance liquid chromatographic method for the determination of nucleosides and their catabolites. Application to cat and rabbit heart perfusates. J Chromatogr (1987) 0.81
The effect of calcium on mitochondrial contact sites: a study on isolated rat hearts. Biochim Biophys Acta (1994) 0.81
Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet. Biochem J (1987) 0.80
A new concept of long-term donor heart preservation: nucleoside transport inhibition. J Heart Lung Transplant (1992) 0.80
The human fatty acid transport protein-1 (SLC27A1; FATP-1) cDNA and gene: organization, chromosomal localization, and expression. Genomics (2000) 0.80
Agents that elevate platelet cAMP stimulate the formation of phosphatidylinositol 4-phosphate in intact human platelets. FEBS Lett (1986) 0.80
The synergistic effect of serotonin and epinephrine on the human platelet at the level of signal transduction. FEBS Lett (1987) 0.80
Inhibition of nucleoside transport by a new series of compounds related to lidoflazine and mioflazine. Eur J Pharmacol (1989) 0.80
Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor. Psychopharmacology (Berl) (1987) 0.80
Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazine. J Pharmacol Exp Ther (1998) 0.79
Desensitization and resensitization of human platelets to 5-hydroxytryptamine at the level of signal transduction. Biochem J (1995) 0.79
Oral pretreatment with mioflazine completely changes the pattern and remarkably prolongs the accumulation of nucleosides in ischemic and reperfused myocardium. Basic Res Cardiol (1986) 0.78
Ultrastructural localisation of carnitine acetyltransferase activity in mitochondria of rat myocardium. Biochim Biophys Acta (1994) 0.78
Serotonin-induced alterations in inositol phospholipid metabolism in human platelets. Biochim Biophys Acta (1987) 0.78
Cardioprotective effects of nucleoside transport inhibition in rabbit hearts. Ann Thorac Surg (1991) 0.78
Metabolic and functional effects of the nucleoside transport inhibitor R75231 in the ischaemic and blood reperfused rabbit heart. Cardiovasc Res (1993) 0.78
The disappeance of adenosine in dog blood after low oral doses of lidoflazine (0.31-5 mg-kg). Eur J Pharmacol (1970) 0.78
Effects of nucleoside transport inhibition on long-term ex vivo preservation of canine hearts. J Thorac Cardiovasc Surg (1992) 0.78
Ouabain increases the calcium concentration in intracellular stores involved in stimulus-response coupling in human platelets. Circ Res (1990) 0.77
Successful transplantation after long-term preservation of dog hearts. Anesthesiology (1992) 0.77
Alkaline phosphatase. II. Conditions affecting determination of total activity in serum. Clin Chem (1976) 0.77
R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule. Prog Clin Biol Res (1989) 0.77
Anticonvulsant action of the nucleoside transport inhibitor, soluflazine, on synaptic and non-synaptic epileptogenesis in the guinea-pig hippocampus. Epilepsy Res (1989) 0.77
Nucleoside transport inhibition mediates lidoflazine-induced cardioprotection during intermittent aortic crossclamping. J Thorac Cardiovasc Surg (1992) 0.77
Inhibition of nucleoside uptake in human erythrocytes by a new series of compounds related to lidoflazine and mioflazine. Eur J Pharmacol (1990) 0.76
Effects of hypothermic ischemia on purine catabolism in canine, primate, and human myocardium. Thorac Cardiovasc Surg (1991) 0.76
The effects of miconazole on the ultrastructure of Candida albicans. Proc R Soc Med (1977) 0.76
The effect of the intracellular calcium chelator Quin-2 on the platelet phosphoinositide metabolism, protein phosphorylation and morphology. Thromb Haemost (1987) 0.76
Catabolism of high energy phosphates during long-term cold storage of donor hearts: effects of extra- and intracellular fluid-type cardioplegic solutions and calcium channel blockers. J Heart Lung Transplant (1991) 0.76
ATP derangement versus free radical-mediated injury. Circulation (1991) 0.75
Adenosine transformation by human red blood cell membranes. Fundam Clin Pharmacol (1995) 0.75
Differences in high-energy phosphate catabolism between the rat and the dog in a heart preservation model. J Heart Lung Transplant (1991) 0.75
The disappearance of adenosine in blood. Effect of lidoflazine and other drugs. Eur J Pharmacol (1970) 0.75
alpha-Ketoaldehydes, specific catalysts for thiol formation from levamisole. Biochem Pharmacol (1979) 0.75
Effect of nucleoside transport inhibition on adenosine and hypoxanthine accumulation in the ischemic human myocardium. Arch Int Pharmacodyn Ther (1993) 0.75
The effect of adenosine transport inhibition on cardiovascular function and survival after severe asphyxia in fetal lambs. Pediatr Res (1993) 0.75
Increased extracellular calcium concentrations in the isolated rat heart: effects on mitochondrial contact site formation. Eur J Morphol (1993) 0.75
Cytochemical localization of NADH oxidase in Candida albicans. J Histochem Cytochem (1977) 0.75
In vivo effectiveness of several nucleoside transport inhibitors in mice and hamsters. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.75
Radioligand binding studies on the nucleoside transport protein. Adv Exp Med Biol (1991) 0.75
The synergistic effect of serotonin and epinephrine at the level of signal transduction. J Cardiovasc Pharmacol (1988) 0.75
Agonist-induced desensitization of 5-HT(2) receptors on cultured calf aortic smooth muscle cells. Neurochem Int (1988) 0.75
Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogs. Arch Int Pharmacodyn Ther (1992) 0.75
New and sensitive reaction for automatic determination of inorganic phosphate and its application to serum. Anal Biochem (1970) 0.75
Measurement of microsomal ATPase activities: a comparison between the inorganic phosphate-release assay and the NADH-coupled enzyme assay. Biochim Biophys Acta (1989) 0.75
Influence of superoxide dismutase on reperfusion injury in donor hearts preserved with Bretschneider-HTK cardioplegic solution. Cardiovasc Surg (1993) 0.75
Population analysis of the non linear red blood cell partitioning and the concentration-effect relationship of draflazine following various infusion rates. Br J Clin Pharmacol (1997) 0.75
Effects of surgery and asphyxia on levels of nucleosides, purine bases, and lactate in cerebrospinal fluid of fetal lambs. Pediatr Res (1994) 0.75
Nucleoside transport inhibition and fMLP-stimulated whole blood luminescence. J Mol Cell Cardiol (1991) 0.75
Cardiac effects of R 79595 and its isomers (R 80122 and R 80123) in an acute heart failure model. A new class of cardiotonic agents with highly selective phosphodiesterase III inhibitory properties. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.75
The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine. Br J Clin Pharmacol (1996) 0.75
Intracellular Ca2+ shifts during the Ca2+ paradox. Basic Res Cardiol (1985) 0.75
Opposite regulation of serotonin-S2 and dopamine-D2 receptors in rat brain following chronic receptor blockade. J Recept Res (1987) 0.75
The nucleoside-transport inhibitor soluflazine (R 64 719) increases the effects of adenosine in the guinea-pig hippocampal slice and is antagonized by adenosine deaminase. Eur J Pharmacol (1987) 0.75
Optimising energy recovery and use of chemicals, resources and materials in modern waste-to-energy plants. Waste Manag (2013) 0.75
Cyclic AMP-phosphodiesterase IIIA1 inhibitors decrease cytosolic Ca2+ concentration and increase the Ca2+ content of intracellular storage sites in human platelets. Biochem Pharmacol (1993) 0.75
New colorimetric method for automatic determination of adenosine at the micromolar level. Anal Biochem (1969) 0.75
The effect of ischemia and reperfusion on mitochondrial contact sites in isolated rat hearts. Histol Histopathol (1995) 0.75
Degradation of myocardial high-energy phosphates during twenty-four hours of cold storage. Effects of cardioplegic versus noncardioplegic arrest. J Thorac Cardiovasc Surg (1992) 0.75
Lipovitellin from the crustacean, artemia salina. Biochemical analysis of lipovitellin complex from the yolk granules. J Biol Chem (1980) 0.75